These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34542806)

  • 1. The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies.
    Wang Y; Xiao S; Xia Y; Wang H
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):152-165. PubMed ID: 34542806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
    Wang X; Xia Y
    Front Immunol; 2019; 10():1667. PubMed ID: 31379858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.
    Zhang J; Jacobi AM; Wang T; Diamond B
    Mol Med; 2008; 14(11-12):675-81. PubMed ID: 18677426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural investigation of FISLE-412, a peptidomimetic compound derived from saquinavir that targets lupus autoantibodies.
    He M; Cheng KF; VanPatten S; Bloom O; Diamond B; Al-Abed Y
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4725-4729. PubMed ID: 28927788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.
    Fattal I; Shental N; Molad Y; Gabrielli A; Pokroy-Shapira E; Oren S; Livneh A; Langevitz P; Pauzner R; Sarig O; Gafter U; Domany E; Cohen IR
    Immunology; 2014 Feb; 141(2):276-85. PubMed ID: 24164500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.
    Diamond B; Bloom O; Al Abed Y; Kowal C; Huerta PT; Volpe BT
    J Intern Med; 2011 Jan; 269(1):36-44. PubMed ID: 21158976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition.
    Putterman C; Diamond B
    J Exp Med; 1998 Jul; 188(1):29-38. PubMed ID: 9653081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
    Hanly JG; Su L; Farewell V; Fritzler MJ
    J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparrós MG; Rueda-Medina B; Ortego-Centeno N
    J Investig Med; 2021 Dec; 69(8):1417-1425. PubMed ID: 34183445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.